Sebastian Haertter - Translat Med Clin Pharmacol, Boehringer Ingelheim Pharma GmbH & Co KG

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 60 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Clinical Pharmacokinetics and Pharmacodynamics of Empagliflozin in Patients with Heart Failure

Juliane Rascher, Dan Cotton,Sebastian Haertter,Martina Brueckmann

BRITISH JOURNAL OF CLINICAL PHARMACOLOGYno. 9 (2024): 2215-2222

引用0浏览0WOS引用

Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper

Aarti Sawant-Basak,Shweta Urva,Jatinder Kaur Mukker,Sebastian Haertter, Dean Mariano,Dolly A. Parasrampuria,Kosalaram Goteti,Ravi Shankar Prasad Singh, Manoj Chiney,Michael Z. Liao, Sandy S. Chang,Rashmi Mehta

Clinical Pharmacology & Therapeutics（2024）

引用0浏览0WOS引用

To blind or not to blind first in human and exploratory clinical trials: Acceleration of development vs. risk of bias

Sebastian Haertter, Jitendar Kanodia,Jack Cook, Jeanette Alicea, Bonnie J. Brennan,Amit Desai, Bela Patel,Lin Pan,Kosalaram Goteti

CTS-CLINICAL AND TRANSLATIONAL SCIENCE（2022）

引用3浏览0WOS引用

Roadmap to 2030 for Drug Evaluation in Older Adults

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 2 (2022): 210-223

引用14浏览0WOS引用

Effect of Itraconazole on the Pharmacokinetics of Faldaprevir in Healthy Subjects

F. Huang,K. Marzin,R. Koenen, K. P. Kammerer,N. Strelkowa,M. Elgadi,S. Haertter

PubMedno. 5 (2021): 189-194

引用0浏览0WOS引用

ICH M9 Guideline in Development on Biopharmaceutics Classification System-Based Biowaivers: An Industrial Perspective from the IQ Consortium

Philip Bransford,Jack Cook,Manish Gupta,Sebastian Haertter,Handan He,Rob Ju,Jitendra Kanodia,Hans Lennernas,David Lindley,James E. Polli,Larissa Wenning,Yunhui Wu

MOLECULAR PHARMACEUTICS（2020）

引用17浏览0WOS引用

Pediatric Extrapolation in Type 2 Diabetes: Future Implications of a Workshop

Jeffrey S. Barrett,Christina Bucci-Rechtweg,S. Y. Amy Cheung,Margaret Gamalo-Siebers,Sebastian Haertter,Janina Karres,Jan Marquard,Yeruk Mulugeta,Cecile Ollivier,Ashley Strougo, Lisa Yanoff,Lynne Yao,Philip Zeitler

Clinical pharmacology and therapeutics/Clinical pharmacology & therapeuticsno. 1 (2020): 29-39

引用11浏览0WOS引用

How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement

Thomas Severin,Solange Corriol-Rohou,Christina Bucci-Rechtweg,Kristina An Haack,Sabine Fuerst-Recktenwald,Pirkko Lepola,Ensio Norjavaara, Martine Dehlinger-Kremer,Sebastian Haertter,S. Y. Amy Cheung

THERAPEUTIC INNOVATION & REGULATORY SCIENCE（2020）

引用2浏览0引用

How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement (vol 54, pg 892, 2020)

Thomas Severin,Solange Corriol-Rohou,Christina Bucci-Rechtweg,Kristina An Haack,Sabine Fuerst-Recktenwald,Pirkko Lepola,Ensio Norjavaara, Martine Dehlinger-Kremer,Sebastian Haertter,S. Y. Amy Cheung

THERAPEUTIC INNOVATION & REGULATORY SCIENCEno. 5 (2020): 1085-1085

引用0浏览0引用

Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation

Jeffrey S. Barrett,Raafat Bishai,Christina Bucci-Rechtweg,Amy Cheung,Solange Corriol‐Rohou,Sebastian Haertter,Angela James,Steven J. Kovacs,Jing Liu, Dennis Potempa,Ashley Strougo,Konstantina Vanevski

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 3.0 (2018): 419-433

引用28浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn